Cypherpunk Technologies Inc. (CYPH) Stock
Financial Services · Asset Management · Member of Other US Stocks
Cypherpunk Technologies Inc. (CYPH) closed at USD 2.62 on 2026-10-14, a change of +390.6 % over the past year, with a market capitalization of USD 321.52M.
Cypherpunk Technologies Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 2.62 |
| 2026-10-13 | 2.84 |
| 2026-10-12 | 2.90 |
| 2026-10-09 | 2.94 |
| 2026-10-08 | 2.81 |
| 2026-10-07 | 3.05 |
| 2026-10-06 | 3.26 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Cypherpunk Technologies Inc. key figures
- Previous close
- USD 2.62 (2026-10-14)
- 1-year change
- +390.6 %
- Market cap
- USD 321.52M
- Enterprise value
- USD 317.86M
- P/E ratio (trailing)
- 5.21
- P/E ratio (forward)
- -33.56
- EPS (trailing)
- 0.58
- EPS (forward)
- -0.09
- PEG ratio
- n/a
- Price to book
- 2.34
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.73
- Employees
- 6
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Cypherpunk Technologies Inc. and compare it with other stocks.
Analyze CYPHAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Cypherpunk Technologies Inc. shares.